Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Cuthbertson

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
BMJ (Clinical Research Ed.)|August 5, 2006
What to tell patients about radioiodine therapyDaniel J Cuthbertson, John Davidson
Evidence-Based Medicine|June 5, 2017
High-intensity exercise offers no additional benefit to moderate-intensity exercise in reducing liver fat in patients with non-alcoholic fatty liver diseaseDaniel J Cuthbertson, Victoria S Sprung
The Journal of Physiology|July 22, 2017
Higher levels of cardiorespiratory fitness keep liver mitochondria happy!Daniel J Cuthbertson, Kelly Bowden Davies
Nature Reviews. Endocrinology|July 17, 2021
Metabolically healthy obesity: time for a change of heart?Daniel J Cuthbertson, John P H Wilding
Frontiers in Nutrition|March 5, 2021
The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?Theresa Hydes, Uazman Alam, Daniel J Cuthbertson
Clinical Medicine (London, England)|March 23, 2023
Diagnosis and management of neuroendocrine tumoursDaniel J Cuthbertson, Rebecca Shankland, Raj Srirajaskanthan
Obesity (Silver Spring, Md.)|December 12, 2022
Reduced muscle strength (dynapenia) in women with obesity confers a greater risk of falls and fractures in the UK BiobankLisa Dowling, Daniel J Cuthbertson, Jennifer S Walsh
Rheumatology (Oxford, England)|March 29, 2024
Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for goutSizheng Steven Zhao, Daniel J Cuthbertson, Uazman Alam
Peptides|February 8, 2018
Newer GLP-1 receptor agonists and obesity-diabetesEmily Brown, Daniel J Cuthbertson, John P Wilding
Endocrine-Related Cancer|July 26, 2013
The optimal use of cardiac imaging in the quantification of carcinoid heart diseaseRebecca Dobson, Daniel J Cuthbertson, Malcolm I Burgess
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
BMJ (Clinical Research Ed.)|August 5, 2006
What to tell patients about radioiodine therapyDaniel J Cuthbertson, John Davidson
Evidence-Based Medicine|June 5, 2017
High-intensity exercise offers no additional benefit to moderate-intensity exercise in reducing liver fat in patients with non-alcoholic fatty liver diseaseDaniel J Cuthbertson, Victoria S Sprung
The Journal of Physiology|July 22, 2017
Higher levels of cardiorespiratory fitness keep liver mitochondria happy!Daniel J Cuthbertson, Kelly Bowden Davies
Nature Reviews. Endocrinology|July 17, 2021
Metabolically healthy obesity: time for a change of heart?Daniel J Cuthbertson, John P H Wilding
Frontiers in Nutrition|March 5, 2021
The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?Theresa Hydes, Uazman Alam, Daniel J Cuthbertson
Clinical Medicine (London, England)|March 23, 2023
Diagnosis and management of neuroendocrine tumoursDaniel J Cuthbertson, Rebecca Shankland, Raj Srirajaskanthan
Obesity (Silver Spring, Md.)|December 12, 2022
Reduced muscle strength (dynapenia) in women with obesity confers a greater risk of falls and fractures in the UK BiobankLisa Dowling, Daniel J Cuthbertson, Jennifer S Walsh
Rheumatology (Oxford, England)|March 29, 2024
Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for goutSizheng Steven Zhao, Daniel J Cuthbertson, Uazman Alam
Peptides|February 8, 2018
Newer GLP-1 receptor agonists and obesity-diabetesEmily Brown, Daniel J Cuthbertson, John P Wilding
Endocrine-Related Cancer|July 26, 2013
The optimal use of cardiac imaging in the quantification of carcinoid heart diseaseRebecca Dobson, Daniel J Cuthbertson, Malcolm I Burgess
Pageof 18